Back to Journals » International Journal of Women's Health » Volume 4

Diagnosis and management of catamenial seizures: a review

Authors Verrotti A, D'Egidio, Agostinelli S, Verrotti, Pavone P 

Received 28 May 2012

Accepted for publication 25 July 2012

Published 28 September 2012 Volume 2012:4 Pages 535—541


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Alberto Verrotti,1 Claudia D’Egidio,1 Sergio Agostinelli,1 Carla Verrotti,2 Piero Pavone3

1Department of Paediatrics, University of Chieti, 2Department of Obstetrics and Gynecology, University of Parma, 3Unit of Paediatrics, University Hospital “Vittorio Emanuele”, Catania, Italy

Abstract: Catamenial epilepsy is defined as a pattern of seizures that changes in severity during particular phases of the menstrual cycle, wherein estrogens are proconvulsant, increasing the neuronal excitability; and progesterone is anticonvulsant, enhancing GABA-mediated inhibition. Thus, changes in serum estradiol/progesterone ratio throughout a normal reproductive cycle bring about an increased or decreased risk of seizure occurrence. To date, there are no specific drug treatments for catamenial epilepsy however, non-hormonal and hormonal therapies have been proposed. The aim of this review is to report preclinical and clinical evidences about the relationship between female reproductive steroids and epileptic seizures, and to describe treatment approaches for catamenial epilepsy.

Keywords: catamenial epilepsy, estrogens, progesterone, neurosteroids

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.